DES Daughters and Their Cancer Risk by Patricia Neighmond; NPR Health & Science. A new study shows that daughters of women who took the anti-miscarriage drug DES, a synthetic estrogen, have a higher risk of developing breast cancer after age 50.http://www.npr.org/templates/story/story.php?storyId=5627698